Cargando…
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
Development of islet autoimmunity precedes the onset of type 1 diabetes in children, however, the presence of autoantibodies does not necessarily lead to manifest disease and the onset of clinical symptoms is hard to predict. Here we show, by longitudinal sampling of islet autoantibodies (IAb) to in...
Autores principales: | Kwon, Bum Chul, Anand, Vibha, Achenbach, Peter, Dunne, Jessica L., Hagopian, William, Hu, Jianying, Koski, Eileen, Lernmark, Åke, Lundgren, Markus, Ng, Kenney, Toppari, Jorma, Veijola, Riitta, Frohnert, Brigitte I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938551/ https://www.ncbi.nlm.nih.gov/pubmed/35314671 http://dx.doi.org/10.1038/s41467-022-28909-1 |
Ejemplares similares
-
Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
por: Kwon, Bum Chul, et al.
Publicado: (2022) -
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022) -
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes
por: Li, Zhiguo, et al.
Publicado: (2022) -
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022) -
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2020)